Rationale: High-density lipoprotein (HDL) is a heterogeneous population of particles.
Differences in the capacities of HDL subfractions to remove cellular cholesterol may explain …

Levels of high-density lipoprotein cholesterol (HDL-C) are inversely related to
cardiovascular disease risk and HDL particles possess a variety of anti-atherosclerotic …

Non-HDL-cholesterol is well recognised as a primary causal risk factor in cardiovascular
disease. However, despite consistent epidemiological evidence for an inverse association …

A wealth of evidence indicates that plasma levels of high-density lipoprotein cholesterol
(HDL-C) are inversely related to the risk of cardiovascular disease (CVD). Consequently …

Numerous randomized clinical trials have established statins as the major standard therapy
for atherosclerotic diseases because these molecules decrease the plasma level of low …

Several recent reports have raised doubts about the atheroprotective role of high-density
lipoprotein cholesterol (HDL-C). Nevertheless, a substantial body of work supports the …

Background Low levels of HDL-C are an independent cardiovascular risk factor associated
with increased premature cardiovascular death. However, HDL-C therapies historically have …

Acute high-density lipoprotein therapies : Current Opinion in Lipidology Acute high-density
lipoprotein therapies : Current Opinion in Lipidology Log in or Register Subscribe to journalSubscribe …

High‐density lipoproteins (HDLs) are antiatherogenic through their role in reverse
cholesterol transport (RCT), that is, the transfer of cholesterol from macrophages in the …

More than 25 years of clinical trial data have established statins as first-line therapy for the
prevention and treatment of atherosclerotic cardiovascular disease. With regard to low …